In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report). The company’s shares closed yesterday at $215.39.

Fri Nov 22 2024 at 10:00 am to Sat Nov 23 2024 at 05:00 pm (GMT-05:00) We have gathered all the information for you in one convenient spot, but please keep in mind that these are subject to change. We ...

Credit: Olga Apanasenko/Shutterstock. FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies for chronic diseases. The ...

The Charles River is ready for the rowers. Starting today, more than 12,000 athletes and tens of thousands of fans will head to Greater Boston’s iconic river for the three-day Head of the ...

Charles River Laboratories Intl ( (CRL)) has released ... TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks ...

Inside a large but nondescript building near the Longfellow Bridge on the Cambridge side of the Charles River is what’s essentially a jet engine. “If you look up, you’ll get a sense of the size,” said ...